Keyphrases
Acute Lung Injury
16%
Asymptomatic Infection
16%
Biosafety Level
16%
Biosafety Level 3
16%
Clinical Outcomes
16%
Coronaviridae Family
16%
Coronavirus Infections
33%
Dipeptidyl peptidase-4 (DPP-4)
33%
Genetically Engineered Mouse Models
16%
High-containment
16%
Human Infection
16%
Lung
16%
Medical Countermeasures
33%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
100%
Mild Infection
16%
Multiple Organ Failure
16%
Non-permissive Hosts
16%
Progeny Virus
16%
Quantitative PCR
16%
Quantitative Real-time
100%
Real-time Quantitative
16%
Real-time RT-PCR
100%
Severe Acute
16%
Single-stranded RNA Virus
16%
Transgenic Mice
33%
Viral Infection
16%
Viral Receptor
16%
World Health Organization
16%
Medicine and Dentistry
Acute Lung Injury
25%
Child
25%
Coronaviridae
25%
Infection
50%
Middle East Respiratory Syndrome
50%
Middle East Respiratory Syndrome Coronavirus
100%
Multiple Organ Dysfunction Syndrome
25%
Positive-Strand RNA Virus
25%
Quantitative Reverse Transcription Polymerase Chain Reaction
100%
Transgenic Mouse
50%
Viral Receptor
25%
Virus Infection
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
25%
Coronaviridae
25%
Genetically Engineered Mouse Strain
25%
Infection
50%
Middle East Respiratory Syndrome
50%
Middle East Respiratory Syndrome Coronavirus
100%
Mouse Model
25%
Multiple Organ Failure
25%
Positive-Strand RNA Virus
25%
Receptor
25%
Transgenic Mouse
50%
Virus Infection
25%
Immunology and Microbiology
Coronaviridae
16%
Genetically Engineered Mouse Strain
16%
Middle East Respiratory Syndrome Coronavirus
100%
Mouse Model
16%
Positive-Strand RNA Virus
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
100%
Transgenic Mouse
33%
Viral Disease
16%